Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Factors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05549505
What this trial is testing

A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery

Who this might be right for
Breast Cancer
Arvinas Inc. 152
Early research (Phase 1)Study completedNCT01445405
What this trial is testing

Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer

Who this might be right for
Carcinoma, SquamousHead and Neck CancerOral Cancer+2 more
National Cancer Institute (NCI) 3
Post-approval studies (Phase 4)Looking for participantsNCT07357597
What this trial is testing

An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.

Who this might be right for
Stomatitis
AstraZeneca 100
Not applicableStudy completedNCT00066183
What this trial is testing

Studying Phosphorus Metabolism

Who this might be right for
Phosphorus Metabolism
National Institute of Dental and Craniofacial Research (NIDCR) 100
Large-scale testing (Phase 3)Looking for participantsNCT07100080
What this trial is testing

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb 500
Not applicableNot Yet RecruitingNCT07593196
What this trial is testing

HER2-positive Metastatic Breast Cancer in Kazakhstan

Who this might be right for
Metastatic Breast Cancer
AstraZeneca 240
Testing effectiveness (Phase 2)Study completedNCT02724020
What this trial is testing

MLN0128 and MLN0128 + MLN1117 Compared With Everolimus in the Treatment of Adults With Advanced or Metastatic Clear-Cell Renal Cell Carcinoma

Who this might be right for
Clear-cell Metastatic Renal Cell Carcinoma
Millennium Pharmaceuticals, Inc. 96
Testing effectiveness (Phase 2)Study completedNCT00261313
What this trial is testing

ACCELERATE: Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast Cancer

Who this might be right for
Breast Cancer
Amgen 80
Early research (Phase 1)Study completedNCT06137482
What this trial is testing

See How Safe and Tolerable Different Doses of REGN13335 Are When Administered Intravenously (IV) or Subcutaneously (SC) to Healthy Adult Participants

Who this might be right for
Healthy Volunteers
Regeneron Pharmaceuticals 56
Early research (Phase 1)Ended earlyNCT03296696
What this trial is testing

Study of AMG 596 in Patients With EGFRvIII Positive Glioblastoma

Who this might be right for
Glioblastoma or Malignant Glioma
Amgen 30
Not applicableUnknownNCT02331966
What this trial is testing

Molecular Pathways Involved in the Pathogenesis and Behavior of Mesenchymal Phosphaturic Tumors Causing Oncogenic Osteomalacia

Who this might be right for
Tumor Induced Oncogenic Osteomalacia
AHEPA University Hospital 10
Testing effectiveness (Phase 2)Ended earlyNCT05325866
What this trial is testing

A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

Who this might be right for
Solid Tumors
Amgen 260
Early research (Phase 1)Study completedNCT04551950
What this trial is testing

Bintrafusp Alfa Combination Therapy in Participants With Cervical Cancer (INTR@PID 046)

Who this might be right for
Cervical Cancer
EMD Serono Research & Development Institute, Inc. 25
Not applicableStudy completedNCT00440882
What this trial is testing

Changes of Transforming Growth Factor b1 and Procollagen III in Patients With Acute Respiratory Distress Syndrome

Who this might be right for
Acute Respiratory Distress Syndrome
Assistance Publique Hopitaux De Marseille 80
Not applicableStudy completedNCT02538562
What this trial is testing

Human Epidermal Growth Factor Receptor 2 (HER2) Advanced Gastric Epidemiology Study in Korea

Who this might be right for
Gastric CancerGastroesophageal Junction Cancer
Hoffmann-La Roche 1,695
Post-approval studies (Phase 4)Study completedNCT03304457
What this trial is testing

Lurasidone Vs Olanzapine on Neurotrophic Biomarkers and Cardiometabolic Parameters in Unmedicated Schizophrenia

Who this might be right for
Schizophrenia
All India Institute of Medical Sciences, Bhubaneswar 100
Testing effectiveness (Phase 2)Study completedNCT00056875
What this trial is testing

Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants

Who this might be right for
Graft Versus Host Disease
University of Michigan 50
Large-scale testing (Phase 3)Looking for participantsNCT06970639
What this trial is testing

A Study Evaluating Furmonertinib Plus Platinum-based Doublet Chemotherapy Versus Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Sensitizing Mutation-Positive Non-squamous Non-Small Cell Lung Cancer (NSCLC) and Brain Metastases

Who this might be right for
NSCLC Patients With Brain Metastasis
Allist Pharmaceuticals, Inc. 380
Not applicableStudy completedNCT06323902
What this trial is testing

Autologous Platelet-rich Plasma as a Treatment for Macular Holes

Who this might be right for
Macular HolesMacular Hole of Left Eye (Disorder)Macular Hole of Right Eye (Disorder)
Clinica Oftalmologica Paredes 13
Testing effectiveness (Phase 2)Study completedNCT00063401
What this trial is testing

Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Who this might be right for
Ovarian CancerPeritoneal NeoplasmsFallopian Tube Neoplasms
Eli Lilly and Company 39
Next Page